TheProfitWatch

ANVS - Annovis Bio, Inc.

Day 1m 10m 60m PreMarket Market AfterHours Gap
1.64 0.2 (12.2%) --- --- 0.0 (0.0%) -0.02 (-1.18%) 0.2 (12.35%) -0.01 (-0.54%) -0.01 (-0.54%)

Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Closed

Earnings & Ratios

Basic EPS:
-0.32
Diluted EPS:
-0.32
Basic P/E:
-5.75
Diluted P/E:
-5.75
RSI(14) 1m:
100.0
VWAP:
1.84
RVol:

Events

Period Kind Movement Occurred At

Related News